Results 261 to 270 of about 86,821 (289)
Some of the next articles are maybe not open access.

Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase

Drug Metabolism and Disposition, 2007
[7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) is a novel multi-targeted Src family kinase inhibitor with demonstrated anticancer activity in preclinical species. Potent kinase inhibition is associated with TG100435 and its major N-oxide metabolite [7-(2,6-dichlorophenyl)-5-methyl ...
Ahmed, Kousba   +3 more
openaire   +2 more sources

Model iron-catalyzed biomimetic cyclization of a cyclic tryptamine N-oxide

The Journal of Organic Chemistry, 1972
C A, Scherer   +3 more
openaire   +2 more sources

Strained Cyclic Acetylenes, VII. Addition of Sulfur and Pyridine-N-oxide to Seven Membered Cycloalkynes

HETEROCYCLES, 1979
Adolf Krebs   +4 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Analogs of Aspergillic Acid. IV. Substituted 2-Bromopyridine-N-oxides and Their Conversion to Cyclic Thiohydroxamic Acids1

Journal of the American Chemical Society, 1950
Elliott Shaw   +3 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Home - About - Disclaimer - Privacy